TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/17/24 16:31 | 6/17/24 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sanders Machelle | NC | D | S | -28 | 6.00 | 0 | -5 | -14 | 28 | D | |||||||||||||||
6/27/23 18:30 | 6/27/23 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sanders Machelle | NC | D | S | -5 | 0.4082 | 0 | -12 | -31 | 25 | D | |||||||||||||||
6/15/23 16:37 | 6/15/23 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sanders Machelle | NC | D | S.d | -32 | 7.98 | 0 | -4 | -14 | 26 | D | |||||||||||||||
6/8/23 21:21 | 6/7/23 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sanders Machelle | NC | D | M.d | 0 | 0.00 | 0 | 36 | 999% | 37 | D | |||||||||||||||
3/5/20 16:16 | 3/3/20 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sanders Machelle | NC | D | P.d | 0 | 0.00 | 0 | 7 | New | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |